Dr. Agarwal's Health Care
CLOSEDIPO Date: 29 Jan - 31 Jan 2025
Listing Date: 4 Feb 2025
Price Range
₹382 to ₹402 per share
Issue Size
3027 Cr
Min Investment
₹13,370
Lot Size
35 Shares
Schedule of Dr. Agarwal's Health Care
Issue open date
29 Jan 2025
Issue close date
31 Jan 2025
UPI mandate deadline
31 Jan 2025 (5 PM)
Allotment finalization
3 Feb 2025
Share credit
4 Feb 2025
Listing date
4 Feb 2025
Mandate end date
13 Feb 2025
Issue size
| Funds Raised in the IPO | Amount |
|---|---|
| Overall | 3027 Cr |
| Fresh Issue | 300 Cr |
| Offer for Sale | 2727 Cr |
Allotment DetailsNew
| Allotment Timeline | Details |
|---|---|
| Allotment Date | 3 Feb 2025 |
| Allotment Link | {Link} |
Grey Market PremiumNew
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
| Date | Ipo Price | GMP | Estimated Listing Price |
|---|---|---|---|
| 4 Feb 2025 | ₹402 | ₹-4 | ₹398 (-1%) |
| 3 Feb 2025 | ₹402 | ₹-4 | ₹398 (-1%) |
| 2 Feb 2025 | ₹402 | ₹0 | ₹402 (0%) |
| 1 Feb 2025 | ₹402 | ₹0 | ₹402 (0%) |
| 31 Jan 2025 | ₹402 | ₹0 | ₹402 (0%) |
| 30 Jan 2025 | ₹402 | ₹1 | ₹403 (0.37%) |
| 29 Jan 2025 | ₹402 | ₹5 | ₹407 (1.24%) |
| 28 Jan 2025 | ₹402 | ₹12 | ₹414 (2.99%) |
| 27 Jan 2025 | ₹402 | ₹13 | ₹415 (3.23%) |
Performance Dr. Agarwal's Health Care
| Issue Price | Listing Gain | Current Market Price | P/L |
|---|---|---|---|
| ₹382 to ₹402 per share | ₹ 395 (-2.2%) | ₹ 405.85 | 0.96% |
About Dr. Agarwal's Health Care
Dr. Agarwal’s Healthcare provides eye care services, including cataract, refractive, and other surgical procedures, along with consultations, diagnostic services, and non-surgical treatments. The company also offers optical products, such as contact lenses, accessories, and eye care-related pharmaceuticals.Its operations are structured into three types of facilities: Primary Facilities, which handle initial diagnosis and clinical investigations; Secondary Facilities, which provide specific services like cataract surgeries; and Tertiary Facilities, which are super-speciality centres. According to the company, these centres are equipped for advanced surgeries, including retinal, corneal, and refractive procedures.
| Founded in | 2010 |
| Managing director | Dr. Amar Agarwal |
| Parent organization | Dr Agarwal's Health Care Ltd |
Financial Overview
Strengths
- Largest network of 209 eye care centers in India.
- Strong leadership and operational history.
- Comprehensive services and product offerings.
- Significant market share and growth potential.
Risks
- Dependency on regulatory approvals.
- Intense market competition.
- Financial and debt-related risks.
- Potential legal challenges.
Subscription Figures
| Category | Subscription (No. of times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | 4.41 |
| Non-Institutional Investors (NIIs) | 0.39 |
| Retail Individual Investors (RIIs) | 0.42 |
| Employee | 0.26 |
| Total | 1.49 |